04.08.26 -- Investing In Early-Stage Oncology With Yosemite's Dan McHugh

Join Life Science Leader Chief Editor Ben Comer on April 30th at 11am eastern for the Return of Radiopharmaceuticals: Overcoming Operational Challenges And New Opportunities virtual event. Panelists will discuss emerging technologies and radioisotopes, what new market opportunities exist, and what manufacturing and delivery challenges remain for radiopharmaceutical developers. Registration is free.

Learn how to mitigate supply chain risks for industrial alcohols and ensure workplace safety through rigorous tracking and reporting protocols.

Anticipate regulatory shifts and supply chain hurdles with agile scenario planning. Move beyond fragmented systems to build a resilient, data-driven foundation for a volatile industry landscape.

Continuous manufacturing delivers agility and precision for pharma, combining automation, reduced manual steps, and quality control to meet regulatory and cost pressures while accelerating development.

This group offers life sciences organizations a deep talent pool, an extensive R&D presence, and dedicated backing by local government investment.

Explore HEOR essentials — from real-world evidence and patient-centered research to HTA — and how they enable smarter policy, innovation, and cost-effective care.

Breakthroughs thrive when biopharma teams work across silos, yet collaboration remains surprisingly difficult. Explore the barriers and why they persist. What will it take to move beyond them?

Companies seeking access to the Brazilian market must navigate more rigorous regulatory requirements, increased scrutiny, and heightened enforcement of good manufacturing practices.